亿胜生物科技有限公司（股票代码：01061）于2026年9月14日发布翌日披露报表，披露当日在香港联交所场内回购9,000股普通股，占当日回购前公司已发行股本（不包括库藏股）总数的约0.00159%。本次回购的每股价格介于每股2.03港元至2.045港元之间，总耗资约18,325港元（约1.83万港元）。
回购完成后，公司已发行股本（不包括库藏股）由564,971,000股减少至564,962,000股，而库藏股由2,035,000股增加至2,044,000股，总已发行股本仍维持在567,006,000股。公司提及其购回授权由股东大会于2026年5月26日通过，授权范围内可再购回的股份总额为56,700,600股。截至目前，公司已根据该授权累计在联交所或其他交易所购回2,044,000股股份，约占授权通过时已发行股本的0.36049%。
公司声明，本次回购事项已获得董事会正式授权批准，相关程序严格遵守香港联交所证券上市规则及适用法律法规的规定。公告由董事方海洲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.